Skip to main content
PHVS logo

Pharvaris N.V.

PHVSNASDAQHealthcareBiotechnology

$31.41Today:- (-)1Y +33.09%

As of Oct 23, 2026 close

Market cap
$2.14B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$21.02$43.25
Volume (live)
-
Avg. volume (3M)
742.80K

Pharvaris (PHVS) Cash Flow Statement

In fiscal 2025 (fiscal year ended Mar 31, 2026), Pharvaris used EUR 137.07M of cash in operating activities and spent EUR 164.62K on capital expenditures. That left free cash flow of −EUR 137.24M.

Pharvaris Cash Flow Statement Analysis

Values in millions EUR

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Pharvaris N.V. (PHVS) - Annual data in millions EUR
BreakdownFY 2025FY 2025FY 2024FY 2024FY 2023FY 2023FY 2022FY 2022FY 2021FY 2020FY 2020FY 2019FY 2018
Period endingMar 2026Dec 2025Mar 2025Dec 2024Mar 2024Dec 2023Mar 2023Dec 2022Dec 2021Mar 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-173.71-173.71-132.40-132.40-99.83-99.83-75.65-75.65-42.66-26.07-25.99-8.03-4.31
Depreciation & Amortization0.420.420.270.270.260.260.150.150.080.010.010.000.00
Stock Based Compensation19.0519.0516.2116.2110.6610.6611.3511.358.201.591.590.120.10
Change in Working Capital7.627.625.895.89-5.86-5.868.388.381.581.571.571.240.29
Change in Accounts Receivable-0.33-0.33-0.03-0.03-0.04-0.040.320.32-0.13-0.36-0.36-0.21-0.05
Change in Inventory0.00-0.00-0.00-0.00-0.000.00-0.000.00
Change in Accounts Payable0.00-0.030.001.650.00-4.170.003.911.660.000.330.270.19
Change in Other Working Capital7.962.165.92-5.42-5.82-0.728.06-2.66-0.031.931.601.170.16
Other Operating Activities9.5411.30-10.10-5.421.722.59-11.39-11.06-11.491.401.320.000.00
Net Cash from Operating Activities-137.07-137.07-120.13-120.13-93.05-93.05-67.16-67.16-44.60-21.50-21.50-6.68-3.92
Investing Activities
Capital Expenditures-0.16-0.16-0.54-0.54-0.09-0.09-0.12-0.12-0.13-0.04-0.04-0.010.00
Net Cash from Investing Activities-0.16-0.16-0.54-0.54-0.09-0.09-0.12-0.12-0.13-0.04-0.04-0.010.00
Financing Activities
Debt Repayment-0.22-0.22-0.16-0.16-0.22-0.22-0.12-0.120.000.00-0.000.00
Common Stock Issued171.74160.832.242.24342.91325.619.618.77143.67102.51102.5122.474.51
Other Financing Activities-10.91-10.910.590.59-17.30-17.30-0.84-0.84-13.15-1.31-1.31-0.840.00
Net Cash from Financing Activities160.61160.612.682.68325.39325.398.658.65143.67101.20101.2021.634.51
Summary
Effect of Forex Changes on Cash-12.42-12.427.497.49-2.86-2.8611.1211.1211.78-1.36-0.000.00
Net Change in Cash10.9510.95-110.50-117.99229.39229.39-47.52-47.52110.7278.3078.3014.940.59
Cash at Beginning of Period280.73280.73391.23391.23161.84161.84209.35209.3598.6320.33-5.394.80
Cash at End of Period291.68291.68280.73280.73391.23391.23161.84161.84209.3598.63-20.335.39
Free Cash Flow-137.24-137.24-120.67-120.67-93.14-93.14-67.29-67.29-44.73-21.54-21.54-6.69-3.92
Supplemental Disclosures
Interest Paid----------0.05--
Income Taxes Paid---2.77-1.11-0.180.03----

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Pharvaris Cash Flow

What is Pharvaris's free cash flow?

Pharvaris had negative free cash flow of EUR 137.24M in fiscal 2025 (fiscal year ended Mar 31, 2026), operating cash flow of −EUR 137.07M minus EUR 164.62K of capital expenditures.

How much does Pharvaris spend on capital expenditures?

Pharvaris spent EUR 164.62K on capital expenditures in fiscal 2025, compared with EUR 538.09K a year earlier.

Does Pharvaris pay dividends or buy back shares?

Pharvaris's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition